153 related articles for article (PubMed ID: 30656820)
1. Risks of colorectal neoplasms and cardiovascular thromboembolic events after the combined use of selective COX-2 inhibitors and aspirin with 5-year follow-up: a meta-analysis.
He P; Yang C; Ye G; Xie H; Zhong W
Colorectal Dis; 2019 Apr; 21(4):417-426. PubMed ID: 30656820
[TBL] [Abstract][Full Text] [Related]
2. Systematic review with meta-analysis: the gastrointestinal benefits of COX-2 selective inhibitors with concomitant use of low-dose aspirin.
Yuan JQ; Yang M; Threapleton DE; Qi XS; Ye DQ; Mao C; Tang JL; Higgins JP
Aliment Pharmacol Ther; 2016 Oct; 44(8):785-95. PubMed ID: 27534608
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.
Gunter BR; Butler KA; Wallace RL; Smith SM; Harirforoosh S
J Clin Pharm Ther; 2017 Feb; 42(1):27-38. PubMed ID: 28019014
[TBL] [Abstract][Full Text] [Related]
4. Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury.
Yang M; Wang HT; Zhao M; Meng WB; Ou JQ; He JH; Zou B; Lei PG
Medicine (Baltimore); 2015 Oct; 94(40):e1592. PubMed ID: 26448006
[TBL] [Abstract][Full Text] [Related]
5. Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials.
Veettil SK; Lim KG; Ching SM; Saokaew S; Phisalprapa P; Chaiyakunapruk N
BMC Cancer; 2017 Nov; 17(1):763. PubMed ID: 29137605
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
[TBL] [Abstract][Full Text] [Related]
7. Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.
Brusselaers N; Lagergren J
BMJ Open; 2018 Jul; 8(7):e021869. PubMed ID: 29982219
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals.
Hur C; Simon LS; Gazelle GS
Cancer; 2004 Jul; 101(1):189-97. PubMed ID: 15222006
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of colorectal cancer in general population and high-risk population: a systematic review and network meta-analysis.
Ma Y; You W; Cao Y; He X; Wang J; Zhang Y; Li J; Li J
Chin Med J (Engl); 2023 Apr; 136(7):788-798. PubMed ID: 37027286
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy of Aspirin in Preventing the Recurrence of Colorectal Adenoma: a Renewed Meta-Analysis of Randomized Trials.
Zhao TY; Tu J; Wang Y; Cheng DW; Gao XK; Luo H; Yan BC; Xu XL; Zhang HL; Lu XJ; Wang YJ
Asian Pac J Cancer Prev; 2016; 17(5):2711-7. PubMed ID: 27268656
[TBL] [Abstract][Full Text] [Related]
11. Risk of myocardial infarction associated with selective COX-2 inhibitors: meta-analysis of randomised controlled trials.
Chen LC; Ashcroft DM
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):762-72. PubMed ID: 17457957
[TBL] [Abstract][Full Text] [Related]
12. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population.
García Rodríguez LA; Barreales Tolosa L
Gastroenterology; 2007 Feb; 132(2):498-506. PubMed ID: 17258728
[TBL] [Abstract][Full Text] [Related]
13. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
Hur C; Chan AT; Tramontano AC; Gazelle GS
Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
[TBL] [Abstract][Full Text] [Related]
15. [Selective cyclooxygenase-2 inhibitors for the prevention of colorectal adenomas: a meta-analysis].
Jin XF; Tong JL; Ran ZH
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1958-61. PubMed ID: 17923032
[TBL] [Abstract][Full Text] [Related]
16. Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.
García Rodríguez LA; Martín-Pérez M; Hennekens CH; Rothwell PM; Lanas A
PLoS One; 2016; 11(8):e0160046. PubMed ID: 27490468
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs.
Patrono C
Curr Cardiol Rep; 2016 Mar; 18(3):25. PubMed ID: 26841787
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: counterpoint.
Jankowski J; Hunt R
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1858-61. PubMed ID: 18708372
[TBL] [Abstract][Full Text] [Related]
19. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
Lanas A; Ferrandez A
Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
